01 12Pfizer Canada Inc.
01 41341325
02 42035314
03 42295035
01 12Voriconazole
01 3Powder for Oral Suspension
02 3Powder for solution
03 6Tablet
01 42011-01-30
02 42018-06-02
03 42018-12-11
Patent Expiration Date : 2011-01-30
Date Granted : 2000-01-18
Brand Name : VFEND
Patent Number : 2035314
Filing Date : 1991-01-30
Strength per Unit : 50 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-01-30
Date Granted : 2000-01-18
Patent Expiration Date : 2018-12-11
Date Granted : 2001-12-11
Brand Name : VFEND
Patent Number : 1341325
Filing Date : 1989-08-11
Strength per Unit : 50 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-11
Date Granted : 2001-12-11
Patent Expiration Date : 2018-12-11
Date Granted : 2001-12-11
Brand Name : VFEND
Patent Number : 1341325
Filing Date : 1989-08-11
Strength per Unit : 200 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-11
Date Granted : 2001-12-11
Patent Expiration Date : 2011-01-30
Date Granted : 2000-01-18
Brand Name : VFEND
Patent Number : 2035314
Filing Date : 1991-01-30
Strength per Unit : 200 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-01-30
Date Granted : 2000-01-18
Patent Expiration Date : 2011-01-30
Date Granted : 2000-01-18
Brand Name : VFEND
Patent Number : 2035314
Filing Date : 1991-01-30
Strength per Unit : 200 mg / vial
Dosage Form : Powder for solution
Human Or VET : Human
Route of Administration : I.V.
Patent Expiration Date : 2011-01-30
Date Granted : 2000-01-18
Patent Expiration Date : 2018-12-11
Date Granted : 2001-12-11
Brand Name : VFEND
Patent Number : 1341325
Filing Date : 1989-08-11
Strength per Unit : 200 mg / vial
Dosage Form : Powder for solution
Human Or VET : Human
Route of Administration : I.V.
Patent Expiration Date : 2018-12-11
Date Granted : 2001-12-11
Patent Expiration Date : 2018-06-02
Date Granted : 2005-04-19
Brand Name : VFEND
Patent Number : 2295035
Filing Date : 1998-06-02
Strength per Unit : 50 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-06-02
Date Granted : 2005-04-19
Patent Expiration Date : 2018-06-02
Date Granted : 2005-04-19
Brand Name : VFEND
Patent Number : 2295035
Filing Date : 1998-06-02
Strength per Unit : 200 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-06-02
Date Granted : 2005-04-19
Patent Expiration Date : 2018-06-02
Date Granted : 2005-04-19
Brand Name : VFEND
Patent Number : 2295035
Filing Date : 1998-06-02
Strength per Unit : 200 mg / vial
Dosage Form : Powder for solution
Human Or VET : Human
Route of Administration : I.V.
Patent Expiration Date : 2018-06-02
Date Granted : 2005-04-19
Patent Expiration Date : 2018-06-02
Date Granted : 2005-04-19
Brand Name : VFEND
Patent Number : 2295035
Filing Date : 1998-06-02
Strength per Unit : 40 mg / ml
Dosage Form : Powder for Oral Suspension
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-06-02
Date Granted : 2005-04-19
